Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Comprehensive Range of Ready-to-Use RNAs

Published: Thursday, February 21, 2013
Last Updated: Wednesday, February 20, 2013
Bookmark and Share
AMSBIO offers customers panels of convenient, ready-to-use RNAs.

AMSBIO has expanded its range of ready-to-use RNA samples to now include mRNA / microRNA tissue preparations and a large number of RNAs from mouse and rat development stages.

With more than 20 years of experience in RNA isolation, AMSBIO has generated over 4000 individual total RNAs ready to go off-the-shelf, many with Bioanalyzer RIN scores to demonstrate their high quality.

Isolated from a variety of tissues - the AMSBIO biorepository of RNA samples covers over 30 species including human, animal, plant, insect and cell line.

Included within the biorepository are a wide range of normal tissue types as well as tissues of human disease conditions, from multiple donors, that are typically difficult to source.

AMSBIO's range of total RNA isolated from major organs (embryonic stages to adult) includes RNA from individual brain regions that are difficult to obtain because of their size and anatomical complexity.

Also available are a comprehensive collection of preparations from placenta, uterus and embryo tissues at different stages of pregnancy plus a complete library of mammary gland specimens from non-pregnant, pregnant, lactating, and involuted animals.

To make purchasing easy for customers - AMSBIO offers customers panels of convenient, ready-to-use RNAs.

Stringent quality control tests are performed on all AMSBIO tissue preparations to confirm the integrity and stability of their RNA.

These purified RNAs are invaluable ready-for-use tools, provided in convenient sizes, for various downstream applications, including microarray hybridization, PCR cDNA synthesis and RT-PCR analysis.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Webinar Discusses DNA Damage in Individual Cells
New on-demand webinar from AMSBIO.
Monday, September 30, 2013
Informative Guide to Gene Silencing & Delivery
AMSBIO’s new guide - 'Top Ten Tips for Gene Silencing & Delivery'.
Tuesday, June 19, 2012
Scientific News
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos